OXT and cancer: The results indicate that most differential metabolites (49/73) are negatively related to the following eight signaling pathways significantly: apoptosis (ko04214), carotenoid biosynthesis (ko00906), furfural degradation (ko00365), steroid biosynthesis (ko00100), phospholipase D signaling pathway (ko04072), axon regeneration (ko04361), choline metabolism in cancer (ko05231), and oxytocin signaling pathway (ko04921).